AI Terminal
Amplitude Surgical
Report Publication Announcement • Nov 18, 2021
1108_iss_2021-11-18_31a302fd-8a3f-4afc-b0d6-523dcaa34b84.pdf
Report Publication Announcement
Open in ViewerOpens in native device viewer
Amplitude Surgical announces its 2021-22 financial calendar
Valence, November 18, 2021, 06:00 pm CET - Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible) ("Amplitude" or the "Group"), French leader on the global surgical technology market for lower-limb orthopedics, announces its 2021-22.
| Events | Dates * |
|---|---|
| 2021-22 Q1 Sales | Thursday November 18, 2021 |
| 2021-22 H1 Sales | Thursday February 17, 2022 |
| 2021-22 H1 Results | Wednesday March 23, 2022 |
| 2021-22 Q3 Sales | Thursday April 21, 2022 |
| 2021-22 Full-Year Sales | Thursday July 21, 2022 |
| 2021-22 Full-Year Results | Wednesday October 19, 2022 |
| 2022-23 Q1 Sales | Thursday November 24, 2022 |
* Subject to modification. Press releases are published after market closes.
Next financial press release
2020-21 H1 Sales: Thursday February 17, 2022, after market.
About Amplitude Surgical
Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents distributing its products in more than 30 countries. Amplitude Surgical operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the United States. At June 30, 2021, Amplitude Surgical had a workforce of 443 employees and recorded sales of nearly 95.5 million euros.
Contacts:
Amplitude Surgical Dimitri Borchtch CFO [email protected] +33 (0)4 75 41 87 41
NewCap Investor Relations Mathilde Bohin/Thomas Grojean [email protected] +33 (0)1 44 71 94 94
NewCap
Media Relations Nicolas Merigeau [email protected] +33 (0)1 44 71 94 98
